PepsReview

Recent activity

2026-10-08 01:24 in 48-week 24.2% vs Phase 3 28.7% — what gives?

One thing I always check on company slides: the estimand/intercurrent-event handling. A 24.2% Phase 2 “efficacy estimand” might count people…